Rahul Singh Parmar: IVF Lab QC – Culture Medium vs. EmbryoGlue
Rahul Singh Parmar, Senior Clinical Embryologist at Indira IVF Group, shared on LinkedIn:
“IVF Lab QC: Culture Medium vs. EmbryoGlue – What’s The Difference?
In Clinical Embryology, every liquid medium has a Specific Role and a distinct Biochemical Composition.
Routine Culture Medium and EmbryoGlue cannot be used interchangeably – each serves a completely different phase of embryo development and the implantation cascade.
Technical Comparison Matrix
Primary Objective:
Culture Medium: To support embryo cleavage, provide metabolic substrate, enable cellular division, and drive blastocyst development (Day 0 to Day 5/6).
EmbryoGlue: To facilitate endometrial adhesion, improve cellular anchoring, and accelerate the implantation cascade (Pre-transfer exposure to the transfer stage).
Biochemical Composition:
Culture Medium: Balanced salts, amino acids, pyruvate, lactate, glucose, and low/moderate albumin (BSA/HSA) concentration.
EmbryoGlue: Recombinant Human Serum Albumin (HSA) blended with High Concentration Hyaluronan (HA).
Viscosity and Physical Properties:
Culture Medium: Low viscosity – ideal for micro-manipulation and gentle handling of oocytes, sperm, and blastomeres.
EmbryoGlue: High viscosity – closely mimics physiological uterine fluid properties to prevent transfer volume drift within the uterine cavity.
Comment Below: Senior Embryologists, does your lab prepare the EmbryoGlue dish immediately after warming during FET cycles, or do you wait for the final transfer call?”
Other articles featuring Rahul Singh Parmar on Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic